An AU$11 billion (US$8.4 billion) merger of Australia’s two biggest gambling companies would have no negative impact on the wagering sector and may even increase competition, a Federal Court judge has ruled.
The Australian Competition Tribunal on Wednesday, November 22, released the reasons behind its divisive decision to clear the proposed mega-merger of Tabcorp and Tatts Group for a second time, after its initial approval was successfully appealed by the competition watchdog and sent back for review.
Tribunal president Justice John Middleton rejected the arguments raised by rival betting operators and the Australian Competition and Consumer Commission (ACCC) that he had made “reviewable errors” when assessing the detriments of creating a merged gaming behemoth.
“The merged entity will be a more effective competitor and the merger is likely to lead to greater competition, particularly in online wagering,” he said.
“This increased competition brings about competition benefits to the racing industry and to consumers.”
Justice Middleton also remarked that the proposed merger was “consistent with the trend towards industry consolidation”, and said the objections of the ACCC and CrownBet were “immaterial.”
Full Content: Financial Review
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas